Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Atezolizumab 1200mg/20ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Pertuzumab 420mg/14ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Martin Dow |
Ondansetron 8mg/4ml |
Product Type |
Product Size |
Tablets |
30'S |
Product Company |
PMS Pharma |
Exemastane 25mg |
Product Type |
Product Size |
Tablet |
10'S |
Product Company |
Martin Dow |
Ondansetron 8mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Getz Pharma |
Trastuzumab 440mg/10ml |
Content | "
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma. | "
Pertuzumab is a monoclonal antibody. . Monoclonal antibodies work by attaching to proteins on or in cancer cells. Human epidermal growth factor 2 (HER2) is a protein that makes cells grow and divide. | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. | Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods). | Ondansetron is one of the medications most commonly used for the empiric treatment of nausea and vomiting. Ondansetron has excellent utility as an antiemetic drug, and it is effective against nausea and vomiting of various etiologies. | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |
Reviews
There are no reviews yet.